November 13, 2019 – November 14, 2019

London, UK

Presentation by:

Karen DeBalsi, PhD,  Senior Study Director, Discovery and Translational Sciences, Metabolon, Inc.

Small Molecules at the Intersection of Health and the Microbiota

Evening Seminar
November 13, 2019 at 6:00 PM

  • Overview of the foundational value of metabolomics in the study of disease and drug development
  • Essential components of Gold Standard metabolomics solutions
  • Key strategies to ensure actionable therapeutic application
  • Reviews of proven microbiome metabolomic case studies

If you’d like to attend please register your interest by emailing

More Information